Dennis M. Lanfear - May 7, 2025 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role: President & CEO, Director
Signature: /s/ Bryan McMichael, as Attorney-in-Fact for Dennis M. Lanfear
Stock symbol: CHRS
Transactions as of: May 7, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/9/2025, 05:58 PM
Previous filing: Jan 22, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lanfear Dennis M	President & CEO, Director	C/O COHERUS BIOSCIENCES, INC., 333 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY	/s/ Bryan McMichael, as Attorney-in-Fact for Dennis M. Lanfear	2025-05-09	0001420822

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRS	Stock Option (Right to Buy)	Award	$0	+375K		$0.00	375K	May 7, 2025	Common Stock	375K	$0.95	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of May 7, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.